Featured Transactions

M&A
Equity
Debt
Restructuring

M&A

  • Finance
    Nov-2024
    Pending
    C$12,100,000,000
    Acquisition of CI Financial Corp.
    Lead Financial Advisor
  • Energy
    Sep-2024
    Pending
    $1,915,000,000
    Sale of 40% interest in the Peregrino field
    to PRIO S.A.
    Sole Financial Advisor
  • Consumer
    Aug-2024
    $1,464,000,000
    Sale to Bansk Group
    Sole Financial Advisor
  • Healthcare
    Jul-2024
    ₹13,630,000,000
    Sale to Mankind Pharma
    Joint Financial Advisor
  • Energy
    Jul-2024
    $5,000,000,000
    Sale of Williston Basin business
    to Devon Energy
    Sole Financial Advisor
  • AeroDefense
    Jun-2024
    $1,290,000,000
    Sale to Cognizant
    Lead Financial Advisor
  • Media
    April-2024
    £1,584,000,000
    Acquisition of Hipgnosis Songs
    Fund Limited
    Sole Financial Advisor
  • Technology
    Apr-2024
    $5,315,000,000
    Sale to Thoma Bravo, L.P.
    Joint Financial Advisor
  • Industrials
    Mar-2024
    $18,250,000,000
    Sale to The Home Depot
    Lead Financial Advisor
Return to Top

Equity

  • Healthcare
    Nov-2024
    $1,500,000,000
    Common Stock Offering on behalf of
    EQT, ADIA and GIC
    Joint Global Coordinator
  • Healthcare
    Sep-2024
    $1,500,000,000
    Common Stock Offering
    Joint Bookrunner
  • Healthcare
    Jun-2024
    $1,000,000,000
    Private Placement of Equity
    Joint Financial Advisor
  • Energy
    May-2024
    €1,400,000,000
    Common Stock Offering
    Joint Global Coordinator
  • Healthcare
    May-2024
    $555,000,000
    Private Placement of Equity
    Sole Placement Agent
  • AeroDefense
    Apr-2024
    $354,000,000
    Initial Public Offering
    Lead Left Bookrunner
  • Finance
    Mar-2024
    $1,050,000,000
    Private Placement of Equity
    Sole Financial Advisor and
    Sole Placement Agent
  • Technology
    Mar-2024
    $700,000,000
    Private Placement of Equity
    Placement Agent
  • Healthcare
    Jul-2023
    $345,000,000
    Initial Public Offering
    Lead Left Bookrunner
Return to Top

Debt

  • Technology
    Jun-2023
    $1,050,000,000
    Credit Facility
    Joint Lead Arranger
  • Healthcare
    May-2023
    $1,383,000,000
    Amendment and Extension of Credit Facility
    Joint Lead Arranger
  • Healthcare
    May-2023
    $1,060,000,000
    Credit Facility
    Joint Lead Arranger
  • Finance
    Feb-2023
    $1,170,000,000
    Credit Facility
    Joint Lead Arranger
  • Consumer
    Feb-2023
    $1,132,000,000
    Amendment and Extension of Credit Facility
    Joint Lead Arranger
  • Technology
    Nov-2022
    $3,496,000,000
    Credit Facility to Finance Acquisition of Intertrust N.V.
    Joint Lead Arranger
  • Technology
    Aug-2022
    $1,720,000,000
    Credit Facility to Finance Acquisition by KKR
    Joint Lead Arranger
  • Power
    May-2022
    $1,543,000,000
    Credit Facility
    Sole Lead Arranger
  • Industrials
    Apr-2022
    $3,526,000,000
    Financing for Acquisition of Ferro Corp. and merger with Chromaflo
    Joint Lead Arranger and Joint Bookrunner
Return to Top

Restructuring

  • AeroDefense
    Aug-2024
    $3,400,000,000
    Reorganization
    Financial Advisor to the Official Committee
    of Unsecured Creditors
  • Healthcare
    Aug-2024
    $4,000,000,000
    Reorganization
    Financial Advisor to the Official Committee
    of Tort Claimants
  • Industrials
    May-2024
    $1,059,000,000
    Restructuring
    Financial Advisor to the Official Committee
    of Unsecured Creditors
  • Healthcare
    Apr-2024
    $8,148,000,000
    Restructuring
    Financial Advisor to the Official Committee
    of Opioid Claimants
  • Healthcare
    Sep-2023
    $660,000,000
    Restructuring
    Financial Advisor to the Company
  • Healthcare
    Jul-2023
    $618,000,000
    Restructuring
    Financial Advisor to the Official Committee
    of Unsecured Creditors
  • Finance
    May-2023
    $832,000,000
    Restructuring
    Financial Advisor to the Company
  • Consumer
    Apr-2023
    $769,000,000
    Restructuring
    Financial Advisor to the Company
  • Healthcare
    Jun-2022
    $5,293,000,000
    Restructuring
    Financial Advisor to the Official Committee
    of Opioid Related Claims
Return to Top

Related content

Back to Investment Banking overview